Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment
Clelia Madeddu, Clelia Donisi, Nicole Liscia, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6489-6489
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Gut microbiota: A new insight into lung diseases
Peijun Ma, Mengmeng Wang, Yun Wang
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113810-113810
Open Access | Times Cited: 80
Novel strategies for cancer immunotherapy: counter-immunoediting therapy
Shaochuan Liu, Qian Sun, Xiubao Ren
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 48
Advances in pyrazolo[1,5-a]pyrimidines: synthesis and their role as protein kinase inhibitors in cancer treatment
Terungwa H. Iorkula, Osasere Jude-Kelly Osayawe, Daniel A. Odogwu, et al.
RSC Advances (2025) Vol. 15, Iss. 5, pp. 3756-3828
Open Access | Times Cited: 2
Integrated network pharmacology and in-silico approaches to decipher the pharmacological mechanism of Selaginella tamariscina in the treatment of non-small cell lung cancer
Sunil Kumar, Faheem Abbas, Iqra Ali, et al.
Phytomedicine Plus (2023) Vol. 3, Iss. 2, pp. 100419-100419
Open Access | Times Cited: 28
Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation
Shuai Lu, Xibo Sun, Zhongbao Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways
Dequan Liu, Xiangyu Che, Guangzhen Wu
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Interactions and communications in lung tumor microenvironment: Chemo/radiotherapy resistance mechanisms and therapeutic targets
Feng Yuan, Ying Jiang, Lin Yang, et al.
Journal of drug targeting (2025), pp. 1-33
Closed Access | Times Cited: 1
Radiological artificial intelligence - predicting personalized immunotherapy outcomes in lung cancer
Laila C. Roisman, Waleed Kian, Alaa Anoze, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 19
Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
Xin Zhang, Xuemei Wang, Lijian Hou, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 18
Dynamic polarization of tumor-associated macrophages and their interaction with intratumoral T cells in an inflamed tumor microenvironment: from mechanistic insights to therapeutic opportunities
Jiashu Han, Luochu Dong, Mengwei Wu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Response to immune checkpoint inhibitor combination therapy in metastatic RET-mutated lung cancer from real-world retrospective data
Ningning Yan, Huixian Zhang, Shujing Shen, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Antimicrobial peptides as drugs with double response against Mycobacterium tuberculosis coinfections in lung cancer
Giulia Polinário, Laura Maria Duran Gleriani Primo, Maiara Alane Baraldi Cerquetani Rosa, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 12
Smart Lipid‐Based Nanoparticles in Lung Cancer Treatment: Current Status and Future Directions
Ramin Yousefpour Shahrivar, Zahra Ahmadi Fakhr, Elham Abbasgholinejad, et al.
Advanced Therapeutics (2023) Vol. 6, Iss. 12
Closed Access | Times Cited: 11
Landscape of adenosine pathway and immune checkpoint dual blockade in NSCLC: progress in basic research and clinical application
Ru-Lan Wang, Zhenkun Liu, Ting Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Bone marrow adipocytes and lung cancer bone metastasis: unraveling the role of adipokines in the tumor microenvironment
Jian Li, Jialu Wu, Yanni Xie, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Role of STING in the treatment of non-small cell lung cancer
Wenhua Tang, Wenjie Zhou, Mei Ji, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Developing a Rhodium(III) Complex to Reprogram the Tumor Immune and Metabolic Microenvironments: Overcoming Multidrug Resistance and Metastasis in Non-Small Cell Lung Cancer
Wenjuan Li, Shanhe Li, Minghui Zhu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 19, pp. 17243-17258
Closed Access | Times Cited: 4
Remodeling of tumor microenvironments by EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
Soo-Min Kim, Jaemoon Koh, Tae Min Kim, et al.
iScience (2025) Vol. 28, Iss. 2, pp. 111736-111736
Open Access
Time Series Analysis in Functional Genomics
Yash Mahajan, I. B. Singh, Muskan Sharma, et al.
(2025), pp. 179-203
Closed Access
Advancements in cellular immunotherapy: overcoming resistance in lung and colorectal cancer
Lijuan Qin, Yuan Li, Juan Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Exploring lung cancer microenvironment: pathways and nanoparticle-based therapies
Arunabh Arandhara, Pallabi Bhuyan, Bhrigu Kumar Das
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Spatial dynamics of the tumor microenvironment in emerging resistance to targeted therapy in EGFR-mutated NSCLC
Satoshi Nakamura, Daisuke Shibahara, Kentaro Tanaka, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Targeting the Tumor Microenvironment in EGFR-Mutant Lung Cancer: Opportunities and Challenges
Jeong Uk Lim, Junyang Jung, Yeon Wook Kim, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 470-470
Open Access
A novel lactylation-related gene signature to predict prognosis and treatment response in lung adenocarcinoma
Hongyi Zhang, Yihao Liu, Xuanguang Li, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Piperlongumine overcomes osimertinib resistance via governing ubiquitination-modulated Sp1 turnover
Ruirui Wang, Qiang Wang, Jinzhuang Liao, et al.
JCI Insight (2025) Vol. 10, Iss. 6
Open Access
Page 1 - Next Page

Scroll to top